Published in Scand J Gastroenterol on January 01, 1973
Plasma ratio of valine, leucine and isoleucine to phenylalanine and tyrosine in liver disease. Gut (1978) 1.03
Can hepatic coma be caused by a reduction of brain noradrenaline or dopamine? Gut (1977) 1.01
Alterations in plasma and CSF amino acids, amines and metabolites in hepatic coma. Ann Surg (1978) 1.00
L-dopa in hepatic coma. Ann Surg (1976) 0.92
Deranged tyrosine metabolism in cirrhosis. Yale J Biol Med (1979) 0.78
Tyramine kinetics and metabolism in cirrhosis. J Clin Invest (1979) 0.77
Consequences of acute renal failure relevant to hepatic failure. Postgrad Med J (1975) 0.75
Some clinical features of liver cell failure: an appraisal of their causes. Gut (1978) 0.75
Sterol-dependent transactivation of the ABC1 promoter by the liver X receptor/retinoid X receptor. J Biol Chem (2000) 4.24
IFN-gamma potentiates atherosclerosis in ApoE knock-out mice. J Clin Invest (1997) 4.18
Increased coronary heart disease in Japanese-American men with mutation in the cholesteryl ester transfer protein gene despite increased HDL levels. J Clin Invest (1996) 3.13
Increased high-density lipoprotein levels caused by a common cholesteryl-ester transfer protein gene mutation. N Engl J Med (1990) 3.02
Scavenger receptor BI promotes high density lipoprotein-mediated cellular cholesterol efflux. J Biol Chem (1997) 2.95
Specific binding of ApoA-I, enhanced cholesterol efflux, and altered plasma membrane morphology in cells expressing ABC1. J Biol Chem (2000) 2.72
Targeted mutation of plasma phospholipid transfer protein gene markedly reduces high-density lipoprotein levels. J Clin Invest (1999) 2.32
Plasma sphingomyelin level as a risk factor for coronary artery disease. Arterioscler Thromb Vasc Biol (2000) 2.16
Use of 51-CrCl-3 in the diagnosis of protein-losing enteropathy. Gut (1967) 2.16
Decreased atherosclerosis in heterozygous low density lipoprotein receptor-deficient mice expressing the scavenger receptor BI transgene. J Biol Chem (1999) 2.15
Sterol upregulation of human CETP expression in vitro and in transgenic mice by an LXR element. J Clin Invest (2000) 2.10
ATP-binding cassette transporter A1 (ABCA1) functions as a cholesterol efflux regulatory protein. J Biol Chem (2001) 2.06
A randomised comparison of InnoScope and Macintosh laryngoscope in simulated difficult tracheal intubation in manikins. Anaesthesia (2012) 1.98
Active chronic hepatitis. Am J Med (1970) 1.85
Treatment of duodenal ulcer with antacid and sulpiride. A double-blind controlled study. Gastroenterology (1979) 1.81
Liver-specific overexpression of scavenger receptor BI decreases levels of very low density lipoprotein ApoB, low density lipoprotein ApoB, and high density lipoprotein in transgenic mice. J Biol Chem (1998) 1.80
Comprehensive analysis of risk factors associating with Hepatitis B virus (HBV) reactivation in cancer patients undergoing cytotoxic chemotherapy. Br J Cancer (2004) 1.76
Biliary cholesterol excretion: a novel mechanism that regulates dietary cholesterol absorption. Proc Natl Acad Sci U S A (1998) 1.73
Clear cell carcinoma of liver. An ultrastructural study. Cancer (1983) 1.72
Drug-induced active chronic hepatitis. Am J Dig Dis (1973) 1.70
The treatment of active chronic hepatitis with 6-mercaptopurine and azathioprine. Australas Ann Med (1967) 1.69
Preferential ATP-binding cassette transporter A1-mediated cholesterol efflux from late endosomes/lysosomes. J Biol Chem (2001) 1.68
Targeted mutation reveals a central role for SR-BI in hepatic selective uptake of high density lipoprotein cholesterol. Proc Natl Acad Sci U S A (1998) 1.67
Hepatitis B virus and cigarette smoking: risk factors for hepatocellular carcinoma in Hong Kong. Cancer Res (1982) 1.64
Hepatic scavenger receptor BI promotes rapid clearance of high density lipoprotein free cholesterol and its transport into bile. J Biol Chem (1999) 1.64
Reduced high density lipoprotein cholesterol in human cholesteryl ester transfer protein transgenic mice. J Biol Chem (1991) 1.63
A double-blind placebo-controlled randomized study of Chinese herbal medicine as complementary therapy for reduction of chemotherapy-induced toxicity. Ann Oncol (2007) 1.63
Apolipoprotein B secretion and atherosclerosis are decreased in mice with phospholipid-transfer protein deficiency. Nat Med (2001) 1.60
Plasma lipid transfer proteins. J Lipid Res (1986) 1.56
Distribution and concentration of cholesteryl ester transfer protein in plasma of normolipemic subjects. J Clin Invest (1990) 1.54
Metabolic fate of chylomicron phospholipids and apoproteins in the rat. J Clin Invest (1979) 1.52
Increased prebeta-high density lipoprotein, apolipoprotein AI, and phospholipid in mice expressing the human phospholipid transfer protein and human apolipoprotein AI transgenes. J Clin Invest (1996) 1.49
A prospective study of HDL-C and cholesteryl ester transfer protein gene mutations and the risk of coronary heart disease in the elderly. J Lipid Res (2004) 1.48
Rat intestine secretes discoid high density lipoprotein. J Clin Invest (1978) 1.47
High density lipoprotein (HDL) particle uptake mediated by scavenger receptor class B type 1 results in selective sorting of HDL cholesterol from protein and polarized cholesterol secretion. J Biol Chem (2001) 1.46
Plasma high-density lipoproteins. N Engl J Med (1978) 1.44
Acid sphingomyelinase-deficient macrophages have defective cholesterol trafficking and efflux. J Biol Chem (2001) 1.44
Histologic prognostic indicators in hepatocellular carcinoma. Cancer (1979) 1.43
Formation of a tetranuclear copper (II) cluster assembled by metal-assisted hydrolysis and desulfurization of bis(3,5-dimethylpyrazolyl)methylphosphine sulfide, MeP(S)(3,5-Me2Pz)2. Inorg Chem (2000) 1.41
Plasma phospholipid transfer protein enhances transfer and exchange of phospholipids between very low density lipoproteins and high density lipoproteins during lipolysis. J Lipid Res (1985) 1.40
Scavenger receptor class B type I as a mediator of cellular cholesterol efflux to lipoproteins and phospholipid acceptors. J Biol Chem (1998) 1.39
Hepatitis B reactivation in patients with hepatocellular carcinoma undergoing systemic chemotherapy. Ann Oncol (2004) 1.39
Increased LDL cholesterol and atherosclerosis in LDL receptor-deficient mice with attenuated expression of scavenger receptor B1. Arterioscler Thromb Vasc Biol (2000) 1.35
Deleterious effect of prednisolone in HBsAg-positive chronic active hepatitis. N Engl J Med (1981) 1.34
Defective HDL particle uptake in ob/ob hepatocytes causes decreased recycling, degradation, and selective lipid uptake. J Clin Invest (2000) 1.33
Increased high density lipoprotein (HDL), defective hepatic catabolism of ApoA-I and ApoA-II, and decreased ApoA-I mRNA in ob/ob mice. Possible role of leptin in stimulation of HDL turnover. J Biol Chem (1999) 1.32
The orphan nuclear receptor LRH-1 potentiates the sterol-mediated induction of the human CETP gene by liver X receptor. J Biol Chem (2001) 1.32
Localization of atherosclerosis susceptibility loci to chromosomes 4 and 6 using the Ldlr knockout mouse model. Proc Natl Acad Sci U S A (2001) 1.29
Structure and thermodynamic properties of high density lipoprotein recombinants. J Biol Chem (1977) 1.28
Human intestinal lipoproteins. Studies in chyluric subjects. J Clin Invest (1979) 1.28
Purification and characterization of a human plasma cholesteryl ester transfer protein. J Biol Chem (1987) 1.26
A randomized study of aprepitant, ondansetron and dexamethasone for chemotherapy-induced nausea and vomiting in Chinese breast cancer patients receiving moderately emetogenic chemotherapy. Breast Cancer Res Treat (2008) 1.26
Thermotropic transitions in rat intestinal plasma membranes studied by differential scanning calorimetry and fluorescence polarization. Biochemistry (1980) 1.25
Organization of the human cholesteryl ester transfer protein gene. Biochemistry (1990) 1.24
ApoE knockout mice expressing human matrix metalloproteinase-1 in macrophages have less advanced atherosclerosis. J Clin Invest (2001) 1.24
Body cholesterol removal: role of plasma high-density lipoproteins. Adv Lipid Res (1980) 1.23
Increased sphingomyelin content of plasma lipoproteins in apolipoprotein E knockout mice reflects combined production and catabolic defects and enhances reactivity with mammalian sphingomyelinase. J Clin Invest (1998) 1.23
Mammalian adipose tissue and muscle are major sources of lipid transfer protein mRNA. J Biol Chem (1991) 1.22
Hypertriglyceridemia and cholesteryl ester transfer protein interact to dramatically alter high density lipoprotein levels, particle sizes, and metabolism. Studies in transgenic mice. J Clin Invest (1993) 1.22
Separation of a plasma phospholipid transfer protein from cholesterol ester/phospholipid exchange protein. J Biol Chem (1983) 1.22
Plasma lipid transfer proteins, high-density lipoproteins, and reverse cholesterol transport. Annu Rev Nutr (1998) 1.20
Clinical features of hepatocellular carcinoma: review of 211 patients in Hong Kong. Cancer (1981) 1.19
Monoclonal antibody inhibition of cholesteryl ester transfer protein activity in the rabbit. Effects on lipoprotein composition and high density lipoprotein cholesteryl ester metabolism. J Clin Invest (1989) 1.16
Home sweet home? A case study of household dust contamination in Hong Kong. Sci Total Environ (2000) 1.15
Atherogenic diet increases cholesteryl ester transfer protein messenger RNA levels in rabbit liver. J Clin Invest (1990) 1.15
Natural history of active chronic hepatitis. I. Clinical features, course, diagnostic criteria, morbidity, mortality and survival. Australas Ann Med (1968) 1.15
Monoclonal antibodies to the Mr 74,000 cholesteryl ester transfer protein neutralize all of the cholesteryl ester and triglyceride transfer activities in human plasma. J Biol Chem (1988) 1.15
Transcriptional profiling reveals global defects in energy metabolism, lipoprotein, and bile acid synthesis and transport with reversal by leptin treatment in ob/ob mouse liver. J Biol Chem (2001) 1.14
Decreased selective uptake of high density lipoprotein cholesteryl esters in apolipoprotein E knock-out mice. Proc Natl Acad Sci U S A (1999) 1.13
An interaction between the human cholesteryl ester transfer protein (CETP) and apolipoprotein A-I genes in transgenic mice results in a profound CETP-mediated depression of high density lipoprotein cholesterol levels. J Clin Invest (1992) 1.12
Stimulation of arterial endothelial cell prostacyclin synthesis by high density lipoproteins. J Biol Chem (1982) 1.11
Relationship of HDL and coronary heart disease to a common amino acid polymorphism in the cholesteryl ester transfer protein in men with and without hypertriglyceridemia. J Lipid Res (1998) 1.11
Effect of cimetidine on gonadal function in man. Br J Clin Pharmacol (1982) 1.11
Unmodified low density lipoprotein causes cholesteryl ester accumulation in J774 macrophages. Proc Natl Acad Sci U S A (1985) 1.11
Urbanization and health in developing countries: a challenge for health for all. World Health Stat Q (1991) 1.10
Decreased early atherosclerotic lesions in hypertriglyceridemic mice expressing cholesteryl ester transfer protein transgene. J Clin Invest (1995) 1.09
A mouse model with features of familial combined hyperlipidemia. Science (1997) 1.09
Scavenger receptor-BI inhibits ATP-binding cassette transporter 1- mediated cholesterol efflux in macrophages. J Biol Chem (2000) 1.08
The implications of the structure of the bactericidal/permeability-increasing protein on the lipid-transfer function of the cholesteryl ester transfer protein. Curr Opin Struct Biol (1998) 1.06
Phospholipid transfer protein gene knock-out mice have low high density lipoprotein levels, due to hypercatabolism, and accumulate apoA-IV-rich lamellar lipoproteins. J Lipid Res (2000) 1.05
A reply. Anaesthesia (2013) 1.05
Novel silver(I)-organic coordination polymers: conversion of extended structures in the solid state as driven by argentophilic interactions. Chem Commun (Camb) (2001) 1.03
Obstetric cholestasis and pruritus of pregnancy. Med J Aust (1967) 1.03
Remodeling of HDL by CETP in vivo and by CETP and hepatic lipase in vitro results in enhanced uptake of HDL CE by cells expressing scavenger receptor B-I. J Lipid Res (1999) 1.02
Australia antigen in active chronic hepatitis in Australia: results in 130 patients from three centres. Aust N Z J Med (1972) 1.01
Regulation of adrenal scavenger receptor-BI expression by ACTH and cellular cholesterol pools. J Lipid Res (1999) 1.01
Conformational and thermodynamic properties of apo A-1 of human plasma high density lipoproteins. J Biol Chem (1976) 1.01
Plasma concentrations of cholesteryl ester transfer protein in hyperlipoproteinemia. Relation to cholesteryl ester transfer protein activity and other lipoprotein variables. Arterioscler Thromb (1991) 1.01
Thermal behavior of human plasma high density lipoprotein. Biochim Biophys Acta (1977) 1.01
Spontaneous regression of hepatocellular carcinoma: a case study. Cancer (1982) 1.00
Cholesteryl ester transfer protein and high density lipoprotein responses to cholesterol feeding in men: relationship to apolipoprotein E genotype. J Lipid Res (1993) 1.00
Spontaneous portosystemic shunt: relationship to spontaneous encephalopathy and gastrointestinal hemorrhage. Dig Dis Sci (1981) 0.99
Increase in plasma cholesteryl ester transfer protein during probucol treatment. Relation to changes in high density lipoprotein composition. Arterioscler Thromb (1991) 0.99
Mechanism of the association of HDL3 with endothelial cells, smooth muscle cells, and fibroblasts. Evidence against the role of specific ligand and receptor proteins. J Biol Chem (1984) 0.99
Plasma cholesteryl ester transfer protein has binding sites for neutral lipids and phospholipids. J Biol Chem (1988) 0.99